BG Medicine is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics. Co.'s focus is on developing products for cardiovascular and other diseases. Co.'s lead product, the BGM Galectin-3 test for heart failure, is a diagnostic test for measuring galectin-3 levels in blood plasma or serum. The BGM Galectin-3 test is being offered for use by clinicians in the U.S. and in certain countries in Europe. Co.'s second cardiovascular diagnostic test, CardioSCORE, is a diagnostic blood test designed to improve the identification of individuals at high risk for near term cardiovascular events, such as heart attack or stroke.
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Service. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20
minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.